Press Releases
Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia
Nov 30, 2022
Merck to Acquire Imago BioSciences, Inc.
Nov 21, 2022
Imago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business Updates
Nov 09, 2022
Imago BioSciences to Participate in Upcoming Investor Conferences
Nov 07, 2022
Imago BioSciences Announces Oral Data Presentations at the Upcoming 64th American Society of Hematology Annual Meeting and Exposition
Nov 03, 2022
Displaying 1 - 5 of 68